Skip to main content

Year: 2021

ART’s ICR 450 Technology Wins Hydrocarbon Processing Award for Best Catalyst Technology

ICR 450, 5th Generation ISODEWAXING® catalyst technology provides additional flexibility and profitability for refiners by delivering breakthrough performance from advanced zeolite developmentThe awards are judged by a third-party advisory board consisting of operating companies, EPCs, licensors, consultants, and equipment/service companiesAward confirms ART’s innovation and technology leadershipCOLUMBIA, Md., Nov. 09, 2021 (GLOBE NEWSWIRE) — Advanced Refining Technologies LLC (ART), the joint venture of US specialty chemicals and materials company W. R. Grace & Co. and US energy company Chevron, today announced that its ICR 450 catalysts have received the 2021 Hydrocarbon Processing award for Best Catalyst Technology. The award honors the downstream energy segment’s leading innovations, as well as outstanding personal...

Continue reading

Sono-Tek Announces Laboratory Expansion for Catalyst Coated Membranes to Meet Demand

Customer Base for Carbon Capture, Fuel Cell, and Electrolysis Applications is Expanding MILTON, NY, Nov. 09, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Sono-Tek Corporation (NASDAQ: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced the expansion of its New York laboratory facilities for catalyst coated membranes.   The expansion is driven by a strong increase in demand for Sono-Tek’s ultrasonic coating machinery used to apply catalyst coatings onto membranes.  The expansion will include the addition of three new coating platforms as well as expanding the existing laboratory facility to accommodate the new machinery. The expansion will be at the New York lab location, which shares a campus with Sono-Tek’s headquarters.  Including the New York lab, Sono-Tek has six applications labs...

Continue reading

Healixa’s Subsidiary PurelyRx Launches Its New Satellite Location

Manhattan, NY, Nov. 09, 2021 (GLOBE NEWSWIRE) — Healixa, Inc. (OTC Pink: EMOR) (“Healixa”, or the “Company”), a technology company focusing on building and acquiring innovative and disruptive technologies in the health-tech, clean water, and green-tech industries, announces it’s subsidiary PurelyRx held a soft launch for PurelyRx’s new satellite location in Coppell, Texas. This announcement is on the heels of PurelyRx launch of its digital pharmacy logistics administrative portal. PurelyRx launched its new satellite location in Coppell, Texas. This location was strategically chosen because of Coppell’s close proximity to the Dallas-Fort Worth metroplex, which has   massive business and technology growth occurring throughout the area, including an Amazon distribution center, a centrally located UPS, and several other Fortune 500...

Continue reading

Results of additional issuance – RIKB 24 0415 – RIKB 28 1115

As stated in paragraph 6 in General Terms of Auction for Treasury bonds, the Government Debt Management offered the equivalent of 10% of the nominal value sold in the auction 5. November, at the price of accepted bids.Series RIKB 24 0415 RIKB 28 1115ISIN IS0000033009 IS0000028249Additional issuance (nominal) 0 0Total outstanding (nominal) 41,175,000,000 92,674,801,519

Continue reading

PTOP Announces MOBICARD Mobile Apps are now available in both the Apple Store & Google Play Store

Cambridge, MA, Nov. 09, 2021 (GLOBE NEWSWIRE) — Peer To Peer Network a.k.a MobiCard Inc. (OTC PINK: PTOP) is happy to announce that we are ahead of schedule with our MOBICARD app reinstatement. As of Thursday, of last week, MOBICARD is officially back in both the Google Play Store, and Apple Store. PTOP’s internal tech development team has worked tirelessly for the last three months to build a quality enterprise worthy back-end and reinstate our apps in their Stores. This is a big deal for our development team, given that PTOP can now manage its MOBICARD app completely in-house. We no longer have to go through a third-party to address any app issues or upgrades. This means a faster response time to issues and no red tape for any added functionality/upgrades. “Our most important objective in this process was to upgrade the MOBICARD...

Continue reading

HEXO Provides Integration Update

OTTAWA, Nov. 09, 2021 (GLOBE NEWSWIRE) — HEXO Corp (“HEXO”, or the “Company”) (TSX: HEXO; NASDAQ: HEXO), today provided an update on the execution of its ongoing integration plan following its recent acquisitions of Redecan, Zenabis Global Inc. (“Zenabis”) and 48North Cannabis Corp. (“48North”). In the coming months, HEXO will cease operations at three production sites to centralize product cultivation, manufacturing, and distribution at its core facilities. “As part of the integration planning process, we completed a comprehensive evaluation of all HEXO facilities to review their capabilities, capacity, and efficiency, and made the decision to centralize operations at our core facilities. This decision is key to achieving our immediate priority of integrating our recent acquisitions to drive growth and profitability through...

Continue reading

IDEX Biometrics ASA – Contemplated Private Placement 9 November 2021

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL.   Oslo, 9 November 2021. IDEX Biometrics ASA (the “Company“), a leading provider of advanced fingerprint identification and authentications solutions, has retained Arctic Securities AS as sole manager and bookrunner (the “Manager“) to advise on and effect a private placement (the “Private Placement“) of new shares in the Company (the “Offer Shares“) to raise gross proceeds of up to the NOK equivalent of USD 25 million. The net proceeds from the Private Placement will be used to cover the forecasted cash requirements until the point of cashflow break even as...

Continue reading

Elis: Disclosure of the number of shares forming the capital and of the number of voting rights as of 31 10 2021

DECLARATION DU NOMBRE D’ACTIONS COMPOSANT LE CAPITALET DU NOMBRE TOTAL DE DROITS DE VOTE AU 31 OCTOBRE 2021 Article L. 233-8-II du Code de CommerceArticle 223-16 du Règlement général de l’AMFNombre d’actions composant le capital social 224 076 007Nombre de droits de vote théoriques 268 754 758Nombre de droits de vote exerçables 268 639 435Cette déclaration est en ligne sur le site internet d’Elis www.elis.com DISCLOSURE OF THE NUMBER OF SHARES FORMING THE CAPITALAND OF THE TOTAL NUMBER OF VOTING RIGHTS AS OF 31 OCTOBER 2021Total number of shares 224,076,007Theoretical number of voting rights 268,754,758Number of exercisable voting rights 268,639,435This disclosure is on Elis web site www.elis.com Contacts Nicolas Buron, Investor Relations Director – Phone: +33 1 75 49 98 30 –...

Continue reading

ALYI and RVLT Discuss $100M Cryptocurrency Backed EV Ecosystem Target (Video)

Dallas, Texas, Nov. 09, 2021 (GLOBE NEWSWIRE) — Alternet Systems, Inc. (OTC Pink: ALYI) (“ALYI”) and Revolt Token (RVLT) (“RVLT”) today announced a video discussion conducted by ALYI CEO Randell Torno and RVLT CEO Henryk Dabrowski detailing the status and future of the ALYI Electric Vehicle (EV) Ecosystem backed by Revolt Token (RVLT). ALYI is an Electric Vehicle and overall Electric Vehicle Ecosystem company concentrating on the East African market with plans to expand into to the overall global developing economic market. ALYI has designed its EV Ecosystem solution to include democratized participation. ALYI has partnered with Revolt Token to finance ALYI’s growth by offering participation in the EV Ecosystem through the sale of Revolt Tokens. To learn more about Revolt Token and how to participate in ALYI’s Electric Vehicle...

Continue reading

ENZO BIOCHEM REPORTS INDUCEMENT AWARDS TO NEW CHIEF EXECUTIVE OFFICER

NEW YORK, NY, Nov. 09, 2021 (GLOBE NEWSWIRE) — Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, announced today that on November 8, 2021, it granted equity awards to Hamid Erfanian. Consistent with the disclosures contained in the Company’s Form 8-K filed with the U.S. Securities and Exchange Commission on October 18, 2021, the Company agreed to grant these equity awards to induce Mr. Erfanian to commence employment as its chief executive officer. These equity awards are being made in reliance on the employment inducement exemption under the New York Stock Exchange’s Listed Company Manual Rule 303A.08, which requires that the Compensation Committee of the Board of Directors approve the inducement awards, which approval was obtained on October 29, 2021, and that the Company...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.